Modulation of Neuroinflammation in Poststroke Rehabilitation: The Role of 12/15-Lipoxygenase Inhibition and Baicalein
Stroke · 2025
DOI: 10.1161/strokeaha.124.049048 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Stroke, 2025. Verfasst von Amir Tajbakhsh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Sciences Research Center (A.T., M.A., M.N.), Shiraz University of Medical Sciences, Iran. Hauptthemen laut MEDLINE: Flavanones, Lipoxygenase Inhibitors, Arachidonate 15-Lipoxygenase, Arachidonate 12-Lipoxygenase. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 92 Literaturangaben.
Abstract (Originalsprache)
Neuroinflammation significantly contributes to stroke pathophysiology, leading to tissue damage and neurological deficits. Baicalein, a potent 12/15-LOX (12/15-lipoxygenase) inhibitor, demonstrates neuroprotective effects by reducing inflammatory lipid mediators, modulating key inflammatory pathways, and attenuating oxidative stress. Experimental studies indicate that baicalein can diminish infarct size and neurological deficits while improving safety and tolerability. Combination therapies with baicalein show promise in enhancing stroke outcomes. Overall, targeting 12/15-LOX and employing baicalein represents a promising approach to modulating neuroinflammation and improving recovery in stroke patients. This review highlights the therapeutic potential of inhibiting the 12/15-LOX pathway and utilizing the natural compound baicalein to mitigate poststroke neuroinflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmaceutical Sciences Research Center (A.T., M.A., M.N.), Shiraz University of Medical Sciences, Iran.
- Department of Medical Biotechnology, School of Advanced Medical Sciences and Technologies (A.T.), Shiraz University of Medical Sciences, Iran.
- Department of Molecular Medicine, School of Advanced Medical Sciences and Technologies (A.T.), Shiraz University of Medical Sciences, Iran.
- Student Research Committee (F.H.-S.), Shiraz University of Medical Sciences, Iran.
- Department of Applied Cell Sciences and Tissue Engineering, School of Advanced Medical Sciences and Technologies (F.H.-S.), Shiraz University of Medical Sciences, Iran.
- Research Center for Traditional Medicine and History of Medicine, Department of Persian Medicine, School of Medicine (M.H.H.), Shiraz University of Medical Sciences, Iran.
ORCID-Profile: Amir Tajbakhsh, Mehdi Abedi, Mohammad Hashem Hashempur, Manica Negahdaripour
Zitieren
APA
Tajbakhsh, A., Hosseinpour-Soleimani, F., Abedi, M., Hashempur, M. H., & Negahdaripour, M. (2025). Modulation of Neuroinflammation in Poststroke Rehabilitation: The Role of 12/15-Lipoxygenase Inhibition and Baicalein. Stroke. https://doi.org/10.1161/strokeaha.124.049048
Vancouver
Tajbakhsh A, Hosseinpour-Soleimani F, Abedi M, Hashempur MH, Negahdaripour M. Modulation of Neuroinflammation in Poststroke Rehabilitation: The Role of 12/15-Lipoxygenase Inhibition and Baicalein. Stroke. 2025. doi:10.1161/strokeaha.124.049048
BibTeX
@article{Tajbakhsh2025,
author = {Tajbakhsh, Amir and Hosseinpour-Soleimani, Fatemeh and Abedi, Mehdi and Hashempur, Mohammad Hashem and Negahdaripour, Manica},
title = {Modulation of Neuroinflammation in Poststroke Rehabilitation: The Role of 12/15-Lipoxygenase Inhibition and Baicalein},
journal = {Stroke},
year = {2025},
doi = {10.1161/strokeaha.124.049048}
}
EUVIMED